College of Medicine, University of Florida, Gainesville, FL, USA.
College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA.
J Diabetes Sci Technol. 2023 Jul;17(4):925-934. doi: 10.1177/19322968221149008. Epub 2023 Jan 29.
Analog insulins, insulin pumps, and continuous glucose monitors (CGM) have revolutionized type 1 diabetes (T1D) treatment over the last 50 years. Nevertheless, less than 20% of patients in the United States reach guideline-based HbA1c targets. The dysfunctional delivery of U.S. health care has further worsened glycemic outcomes among structurally disadvantaged groups such as non-Hispanic Black and low-income populations. Administrative complexities resulting from mixed insurance coverage and delivery systems, incongruity between effective policies and reimbursement, structural racism, and implicit biases have led to high diabetes care-related costs, provider scarcity and burnout, and patient diabetes distress. The Extension for Community Healthcare Outcomes (ECHO) Diabetes tele-education outreach model was created to increase self-efficacy among primary care providers through a combination of weekly didactic sessions led by a team of diabetes experts and access to community-based peer coaches. As an evolution of ECHO Diabetes, Blue Circle Health has been established as a philanthropically funded health care delivery system, using a whole-person, individualized approach to T1D care for adults living in underserved communities. The program will provide direct-to-patient telehealth services, including diabetes education, management, and related psychological care regardless of ability to pay. Community-based diabetes support coaches will serve as the primary point of contact, or guide on the "Blue Circle Health Member Journey." Access to needed insulins, supplies, and CGMs will be provided at no cost to the individual. Through a continuous learning and improvement model, a person-centered, equitable, accessible, and effective health care delivery model will be built for people living with T1D.
在过去的 50 年中,模拟胰岛素、胰岛素泵和连续血糖监测仪 (CGM) 彻底改变了 1 型糖尿病 (T1D) 的治疗方式。尽管如此,在美国,只有不到 20%的患者达到了基于指南的 HbA1c 目标。美国医疗保健服务的功能失调进一步恶化了在非西班牙裔黑人和低收入人群等结构性弱势群体中的血糖控制结果。混合保险覆盖和交付系统导致的行政复杂性、有效政策和报销之间的不匹配、结构性种族主义和隐性偏见,导致与糖尿病护理相关的成本高、医疗服务提供者短缺和倦怠以及患者的糖尿病困扰。扩展社区医疗保健成果 (ECHO) 糖尿病远程教育外展模式是为了通过每周由一组糖尿病专家领导的专题会议和获得基于社区的同行教练的机会,提高初级保健提供者的自我效能而创建的。作为 ECHO 糖尿病的发展,Blue Circle Health 已作为一个慈善资助的医疗保健提供系统建立,采用整体人、个体化的方法来为生活在服务不足社区的成年人提供 T1D 护理。该计划将为患者提供直接的远程医疗服务,包括糖尿病教育、管理和相关的心理护理,无论其支付能力如何。基于社区的糖尿病支持教练将作为主要联系人,或作为“Blue Circle Health 会员之旅”的指南。将免费为个人提供所需的胰岛素、用品和 CGM。通过持续学习和改进模式,将为 T1D 患者建立一个以人为本、公平、可及和有效的医疗保健提供模式。